(Q79151697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Paola Caramaschi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Alessandro Volpe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Ilaria Tinazzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Lisa Maria Bambara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Antonio Carletto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Domenico Biasi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

28 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

203-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006704%20AND%20SRC:MED&resulttype=core&format=json

Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules

19 December 2019

cites work

1 reference

12 December 2020

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?

1 reference

12 December 2020

Cytokine production in scleroderma patients: effects of therapy with either iloprost or nifedipine

1 reference

12 December 2020

Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy

1 reference

12 December 2020

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

1 reference

12 December 2020

Intermittent iloprost infusion therapy of pulmonary hypertension in scleroderma--a pilot study

1 reference

12 December 2020

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

1 reference

12 December 2020

Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020